Invitae Stock

Invitae OpEx/Revenue

Delisted·Aug 7, 2024

The Operating Expenses to Revenue Ratio of Invitae (NVTAQ) as of Aug 25, 2026 is 130.52 %. In the previous year, Operating Expenses to Revenue Ratio was 113.60 % — a change of 14.90% (higher).

OpEx/Revenue

130.52 %

YoY

14.90%

Last updated:

Operating Expenses to Revenue Ratio of Invitae is 2026 130.52 % . Operating Expenses to Revenue Ratio of Invitae was 2025 113.60 % . It decreases by 14.90% higher compared to the previous year.

The Invitae OpEx/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OpEx/Revenue
Date
OpEx/Revenue
Jan 1, 2016
274.33 USD
Jan 1, 2017
125.97 USD
Jan 1, 2018
78.35 USD
Jan 1, 2019
101.74 USD
Jan 1, 2020
182.34 USD
Jan 1, 2021
132.82 USD
Jan 1, 2022
113.60 USD
Jan 1, 2023
130.52 USD
The Invitae OpEx/Revenue history
YEAROpEx/RevenueYoY
130.52 %+14.90%
113.60 %-14.48%
132.82 %-27.16%
182.34 %+79.22%
101.74 %+29.85%
78.35 %-37.80%
125.97 %-54.08%
274.33 %-60.95%
702.47 %-67.57%
2,166.15 %
Access this data via the Eulerpool API

Invitae Stock analysis

What does Invitae do? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Invitae stock

Operating Expenses to Revenue Ratio of Invitae is 130.52 % in 2026.

Operating Expenses to Revenue Ratio of Invitae changed from 113.60 % to 130.52 %, representing a 14.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Expenses to Revenue Ratio Invitae since 2006 – with annual values, charts, and detailed analysis.

The OpEx/Revenue ratio measures total operating expenses as a percentage of revenue. Declining ratios suggest improving operational leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Expenses to Revenue Ratio's Invitae with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Expenses to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Expenses to Revenue Ratio.

Access this data via the Eulerpool API

Margins — Invitae

All Key Metrics — Invitae